{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:14Z","timestamp":1792726154843,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.radonc.2021.03.020","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T16:40:54Z","timestamp":1616517654000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer"],"prefix":"10.1016","volume":"159","author":[{"given":"Tara","family":"Behroozian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-6070","authenticated-orcid":false,"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-6783","authenticated-orcid":false,"given":"Julia","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Szumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-5257","authenticated-orcid":false,"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.03.020_b0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.soncn.2011.02.009","article-title":"Evidence-based skin care management in radiation therapy: clinical update","volume":"27","author":"McQuestion","year":"2011","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.radonc.2021.03.020_b0010","series-title":"The Breast (Fifth Edition)","first-page":"716","article-title":"Radiation complications and their management","author":"Freedman","year":"2018"},{"key":"10.1016\/j.radonc.2021.03.020_b0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1471-2407-10-508","article-title":"Predictive factors of radiation-induced skin toxicity in breast cancer patients","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2021.03.020_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijrobp.2014.09.022","article-title":"Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy","volume":"91","author":"Pignol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.03.020_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","article-title":"Radiodermatitis: a review of our current understanding","volume":"17","author":"Singh","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.radonc.2021.03.020_b0030","first-page":"885","article-title":"Radiation dermatitis: recognition, prevention, and management","volume":"31","author":"Leventhal","year":"2017","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.radonc.2021.03.020_b0035","doi-asserted-by":"crossref","first-page":"E742","DOI":"10.1016\/j.ijrobp.2018.07.1984","article-title":"Characterizing the effects of radiation dermatitis on quality of life","volume":"102","author":"Rzepecki","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0040","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1016\/j.ijrobp.2017.06.688","article-title":"Risk factors for the development of acute radiation dermatitis in breast cancer patients","volume":"99","author":"Parker","year":"2017","journal-title":"Int J Radiat Oncol [Internet]"},{"key":"10.1016\/j.radonc.2021.03.020_b0045","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0050","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.03.020_b0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.breast.2019.09.009","article-title":"A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis","volume":"50","author":"Lam","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2021.03.020_b0060","first-page":"2265","article-title":"Radiation dermatitis assessment tools used in breast cancer: a systematic review of measurement properties","volume":"29","author":"Behroozian","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2021.03.020_b0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.breast.2015.01.008","article-title":"RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements","volume":"24","author":"Huang","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2021.03.020_b0070","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/jocn.13430","article-title":"An integrative review of skin assessment tools used to evaluate skin injury related to external beam radiation therapy","volume":"26","author":"Baines","year":"2017","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.radonc.2021.03.020_b0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1477-7525-8-104","article-title":"Health care providers underestimate symptom intensities of cancer patients: a multicenter European study","volume":"8","author":"Laugsand","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.radonc.2021.03.020_b0080","first-page":"802","article-title":"The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline","volume":"14","author":"Bolderston","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2021.03.020_b0085","series-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.radonc.2021.03.020_b0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clon.2016.01.011","article-title":"Do patient-reported outcome measures agree with clinical and photographic assessments of normal tissue effects after breast radiotherapy? The experience of the standardisation of breast radiotherapy (START) trials in early breast cancer","volume":"28","author":"Haviland","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2012.03.019","article-title":"Phase II trial of 3D-conformal accelerated partial breast irradiation: Lessons learned from patients and physicians\u2019 evaluation","volume":"103","author":"Azoury","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-119-2-199307150-00005","article-title":"Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group","volume":"119","author":"Von Roenn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.03.020_b0105","article-title":"Persistent pain after breast cancer treatment","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.radonc.2021.03.020_b0125","doi-asserted-by":"crossref","DOI":"10.1177\/1178223419835547","article-title":"Using the dermatology life quality index to assess how breast radiodermatitis affects patients\u2019 quality of life","volume":"13","author":"Beamer","year":"2019","journal-title":"Breast Cancer Basic Clin Res"},{"key":"10.1016\/j.radonc.2021.03.020_b0130","first-page":"E742","article-title":"Characterizing the effects of radiation dermatitis on quality of life: a prospective survey-based study","volume":"102","author":"Rzepecki","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.radonc.2021.03.020_b0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijrobp.2010.05.065","article-title":"Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4)","volume":"81","author":"Neben-Wittich","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.03.020_b0140","first-page":"529","article-title":"A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy","volume":"34","author":"Schnur","year":"2011","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.radonc.2021.03.020_b0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2019.01.036","article-title":"Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial","volume":"134","author":"Bhattacharya","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.radonc.2016.08.021","article-title":"Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial","volume":"121","author":"Pignol","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.03.020_b0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/wound.2012.0404","article-title":"Breast reconstruction after radiotherapy","volume":"3","author":"Yoshimoto","year":"2014","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.radonc.2021.03.020_b0160","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1016\/j.clbc.2018.03.008","article-title":"Prospective study of breast radiation dermatitis","volume":"18","author":"Drost","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2021.03.020_b0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(01)01576-0","article-title":"Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy","volume":"51","author":"Szumacher","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021061466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021061466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:15:09Z","timestamp":1759122909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021061466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"alternative-id":["S0167814021061466"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.03.020","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}